These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23090561)

  • 21. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of venous thromboembolism with drospirenone-containing oral contraceptives.
    Brown DA; Vartan CM
    Am J Health Syst Pharm; 2011 Jun; 68(11):1003-10. PubMed ID: 21593228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The INAS-OC study.
    Lidegaard O
    Contraception; 2014 Dec; 90(6):617-8. PubMed ID: 25261151
    [No Abstract]   [Full Text] [Related]  

  • 24. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of a new oral contraceptive containing drospirenone.
    Heinemann LA; Dinger J
    Drug Saf; 2004; 27(13):1001-18. PubMed ID: 15471507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reply to letter to the editor: "The INAS-OC study".
    Dinger J
    Contraception; 2014 Dec; 90(6):618-21. PubMed ID: 25263612
    [No Abstract]   [Full Text] [Related]  

  • 27. [Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].
    Botzenhardt S; Toni I; Rascher W; Neubert A
    Klin Padiatr; 2013 Sep; 225(5):268-76. PubMed ID: 23979828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of the contraceptive pill and venous thromboembolism.
    Hannaford PC
    Thromb Res; 2011 Feb; 127 Suppl 3():S30-4. PubMed ID: 21262435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venous thromboembolism in adolescents associated with drospirenone-containing oral contraceptives - two case reports.
    Toni I; Neubert A; Botzenhardt S; Gratzki N; Rascher W
    Klin Padiatr; 2013 Sep; 225(5):266-7. PubMed ID: 23975850
    [No Abstract]   [Full Text] [Related]  

  • 30. Hormonal contraception and venous thromboembolism.
    Lidegaard Ø; Milsom I; Geirsson RT; Skjeldestad FE
    Acta Obstet Gynecol Scand; 2012 Jul; 91(7):769-78. PubMed ID: 22568831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Seeger JD; Loughlin J; Eng PM; Clifford CR; Cutone J; Walker AM
    Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
    Plu-Bureau G; Sabbagh E; Hugon-Rodin J
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboembolism associated with the new contraceptive Yasmin.
    van Grootheest K; Vrieling T
    BMJ; 2003 Feb; 326(7383):257. PubMed ID: 12560278
    [No Abstract]   [Full Text] [Related]  

  • 34. Does the Progestogen Used in Combined Hormonal Contraception Affect Venous Thrombosis Risk?
    Han L; Jensen JT
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):683-98. PubMed ID: 26598309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk of deep venous thrombosis with oral contraceptives containing drospirenone.
    Dunn N
    BMJ; 2011 Apr; 342():d2519. PubMed ID: 21511807
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use.
    Dulicek P; Ivanova E; Kostal M; Sadilek P; Beranek M; Zak P; Hirmerova J
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):797-802. PubMed ID: 28884608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
    Sidney S; Cheetham TC; Connell FA; Ouellet-Hellstrom R; Graham DJ; Davis D; Sorel M; Quesenberry CP; Cooper WO
    Contraception; 2013 Jan; 87(1):93-100. PubMed ID: 23083525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drospirenone-related venous thromboembolism risk: "the rest of the story".
    Casey PM; Files JA; Mayer AP
    J Womens Health (Larchmt); 2013 May; 22(5):467-8. PubMed ID: 23659485
    [No Abstract]   [Full Text] [Related]  

  • 39. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts?
    Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to the letter from Dr. Szarewski.
    Sidney S
    Contraception; 2013 Apr; 87(4):506-7. PubMed ID: 23246306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.